Financial Performance - The company's operating revenue for Q1 2024 was CNY 242,947,613.90, representing a year-over-year increase of 2.46%[4] - The net profit attributable to shareholders was CNY 46,433,587.75, with a slight increase of 0.34% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 3.78% to CNY 44,338,767.45[4] - Basic and diluted earnings per share were both CNY 0.24, down 25.00% from the previous year[4] - The net profit for Q1 2024 was CNY 46,528,696.97, slightly up from CNY 46,278,194.85 in Q1 2023, reflecting a growth of 0.5%[31] - The company reported a net cash flow from operating activities of -CNY 27,435,595.76 in Q1 2024, a significant decrease compared to CNY 57,256,098.62 in Q1 2023[33] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,309,902,841.86, reflecting a slight increase of 0.51% from the end of the previous year[4] - Total assets as of March 31, 2024, were CNY 2,309,902,841.86, slightly up from CNY 2,298,254,162.50 as of December 31, 2023[16] - Total liabilities decreased to CNY 93,501,323.29 in Q1 2024 from CNY 129,738,193.69 in Q4 2023, a reduction of 28%[16] - The total liabilities decreased to CNY 93,302,554.78 in Q1 2024 from CNY 129,545,788.36 in Q1 2023, a reduction of 28%[30] - The total equity increased to CNY 2,216,540,562.98 in Q1 2024 from CNY 2,168,559,904.00 in Q1 2023, reflecting a growth of 2.2%[28] Cash Flow - The net cash flow from operating activities was negative at CNY -27,523,430.48, a significant decline of 148.07% year-over-year[4] - Cash flow from operating activities for Q1 2024 was negative at CNY -27,523,430.48, compared to a positive CNY 57,256,098.62 in Q1 2023, reflecting a significant decline[23] - The cash inflow from operating activities totaled CNY 220,864,206.43 in Q1 2024, down from CNY 255,295,192.04 in Q1 2023, a decrease of 13.5%[33] - The total cash outflow from investing activities in Q1 2024 was CNY 284,394,566.29, significantly higher than CNY 6,014,609.35 in Q1 2023[24] - The net cash flow from financing activities was -$3,411.30, indicating a significant outflow of funds[34] - The net increase in cash and cash equivalents for the period was -$111,499,396.65, showing a decrease in liquidity[34] Research and Development - The company's R&D expenses increased by 31.33%, indicating a focus on new product development[6] - Research and development expenses increased to CNY 12,127,695.04 in Q1 2024, up from CNY 9,234,747.96 in Q1 2023, representing a growth of 31%[18] Inventory and Prepayments - The company reported a significant increase of 294.81% in prepayments, primarily due to project payments made by subsidiaries[6] - The company experienced a 30.01% increase in inventory, attributed to stockpiling for production and sales[6] - The company reported a significant increase in inventory, rising to CNY 139,050,042.07 in Q1 2024 from CNY 106,953,351.79 in Q4 2023, an increase of 30%[15] - The company’s inventory increased to CNY 139,050,042.07 as of March 31, 2024, compared to CNY 106,953,351.79 at the end of 2023, indicating a rise of 30.3%[26]

国浩律师（上海）事务所 关 于 江苏常青树新材料科技股份有限公司 2023 年年度股东大会 之 见证法律意见书 上海市北京西路 968 号嘉地中心 27 层 邮编：200041 27F, Garden Square, No. 968 West Beijing Road, Shanghai 200041, China 电话/Tel: +86 21 5234 1668 传真/Fax: +86 21 5243 3320 网址/Website: http://www.grandall.com.cn 2024 年 4 月 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于江苏常青树新材料科技股份有限公司 2023 年年度股东大会之见证法律意见书 致：江苏常青树新材料科技股份有限公司 江苏常青树新材料科技股份有限公司（以下简称"公司"）2023 年年度股东 大会于 2024 年 4 月 23 日 13 时 30 分在江苏省镇江新区青龙山路 3 号公司二楼会 议室召开，国浩律师（上海）事务所（以下简称"本所"）接受公司的委托，指 派秦桂森律师、黄靖渝律师（以下简称"本所律师"）出席会议，并依据《中华 人民共和 ...

证券代码：603125 证券简称：常青科技 公告编号：2024-20 江苏常青树新材料科技股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 | 1、出席会议的股东和代理人人数 | 15 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 144,444,500 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 75.0166 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会的召集、召开及表决程序符合《公司法》《上市公司股东大会 规则》《公司章程》的有关规定。本次股东大会由公司董事会召集，由董事长、 总经理孙秋新主持。 (一) 股东大会召开的时间：2024 年 4 月 23 日 (二) 股东大会召开的地点：江苏省镇江新区青龙山路 3 号公司二楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情 ...

江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2024-019 江苏常青树新材料科技股份有限公司 关于使用暂时闲置自有资金进行现金管理的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 现金管理产品名称：结构性存款 现金管理金额：20,000 万元人民币 履行的审议程序：公司于 2024 年 4 月 1 日召开的第二届董事会第四次会 议及第二届监事会第三次会议，审议通过了《关于公司拟使用暂时闲置自有资金 进行现金管理的议案》，同意公司在不超过人民币 30,000 万元的额度内使用闲 置自有资金进行现金管理，上述额度自董事会审议通过之日起 12 个月内可滚动 计算。该事项在董事会审批权限内，无须提交股东大会审议。 特别风险提示：公司本次购买的理财产品均为保证本金的低风险产品， 但结构性存款产品可能面临多重风险因素，包括但不限于政策风险、市场风险、 流动性风险、产品不成立风险、信息传递风险、管理风险、产品提前终止风险、 不可抗力及意外事件风险、信用风险、估值风险、欠 ...

江苏常青树新材料科技股份有限公司 2023 年年度股东大会会议资料 二〇二四年四月二十三日 | 2023 | 年年度股东大会会议须知 | 1 | | --- | --- | --- | | 2023 | 年年度股东大会会议议程 | 3 | | 议案一：关于公司 | 2023 年度董事会工作报告的议案 | 5 | | 议案二：关于公司 | 年度监事会工作报告的议案 12 2023 | | | 议案三：关于公司 | 2023 年度报告及其摘要的议案 16 | | | 议案四：关于公司 | 2023 年度财务决算报告的议案 17 | | | 议案五：关于公司 | 2023 年度利润分配方案的议案 22 | | | 议案六：关于公司 | 2024 年度财务预算报告的议案 23 | | | 议案七：关于公司 | 年度董事薪酬方案的议案 26 2024 | | | 议案八：关于公司 | 2024 年度监事薪酬方案的议案 27 | | | 议案九：关于聘请上会会计师事务所(特殊普通合伙)为公司 | 2024 年度审计机构的议案 28 | | | 议案十：关于公司 | 2024 年度申请银行授信额度的议案 31 | | | ...

江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2024-018 江苏常青树新材料科技股份有限公司 关于召开 2023 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： （http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频录播和网络互动 投资者可于 2024 年 04 月 19 日(星期五)至 04 月 25 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 securities@cqs-hm.com进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 江苏常青树新材料科技股份有限公司（以下简称"公司"）已于 2024 年 4 月 2 日发布公司 2023 年年度报告，为便于广大投资者更全面深入地了解公司 2023年度经营成果、财务状况，公司计划于2024年04月26日 下午 13:00-14:30 举行 2023 年度业绩说明会，就投资者关心的问题进行交流。 一、 ...

江苏常青树新材料科技股份有限公司 证券代码：603125 证券简称：常青科技 公告编号：2024-017 江苏常青树新材料科技股份有限公司 关于使用暂时闲置自有资金进行现金管理到期赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）于 2023 年 4 月 28 日召开第一届董事会第十次会议、第一届监事会第十次会议，审议通过了《关 于公司拟使用暂时闲置自有资金进行现金管理的议案》，同意公司在不超过人民 币 20,000 万元的额度内使用闲置自有资金进行现金管理，上述额度自董事会审 议通过之日起 12 个月内可滚动计算。独立董事对该项议案发表了独立意见。该 事项在董事会审批权限内，无须提交股东大会审议。 近日，公司使用闲置自有资金购买的部分理财产品到期赎回，现就相关事宜 公告如下： 二、截至本公告日，公司授权期限内使用自有资金委托理财的情况 单位：万元 序 号 受托方 产品 类型 投资金额 收益类型 起息日 到期日 到期 状态 预期年化 收益率 是否 赎回 实际 收益 ...

Financial Performance - The company's operating revenue for 2023 reached ¥1,019,011,837.6, representing a 5.75% increase compared to ¥963,610,053.57 in 2022[20]. - Net profit attributable to shareholders for 2023 was ¥212,572,316.87, an increase of 11.5% from ¥190,652,700.11 in 2022[20]. - The net cash flow from operating activities increased significantly by 80.96% to ¥205,598,020.53 in 2023, compared to ¥113,615,366.34 in 2022[20]. - The total assets of the company grew by 136.04% to ¥2,298,254,162.5 at the end of 2023, up from ¥973,667,449.36 at the end of 2022[20]. - The weighted average return on equity decreased to 12.58% in 2023, down from 25.63% in 2022, a reduction of 13.05 percentage points[21]. - The basic earnings per share for 2023 was ¥1.20, a decrease of 9.09% compared to ¥1.32 in 2022[21]. - The company reported a total of ¥5,119,269.62 in non-recurring gains and losses for 2023, compared to ¥587,842.58 in 2022[25]. - The company's gross profit for 2023 was CNY 32,257.4 million, reflecting a growth of 9.13% year-on-year[71]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was CNY 20,745.30 million, up by 9.15% from the previous year[71]. Shareholder Returns - The company plans to distribute a cash dividend of 2.30 CNY per 10 shares, totaling 44,286,500 CNY (including tax) based on a total share capital of 192,550,000 shares as of December 31, 2023[4]. - The cash dividend distribution represents 20.83% of the net profit attributable to ordinary shareholders in the consolidated financial statements[187]. - The company will increase its share capital by 4.5 shares for every 10 shares held, resulting in a total increase of 86,647,500 shares, raising the total share capital to 279,197,500 shares[4]. Risk Management - The company emphasizes that forward-looking statements regarding future plans and strategies are subject to known and unknown risks and uncertainties, which may lead to significant differences from actual performance[5]. - The company has detailed potential risk factors in the "Management Discussion and Analysis" section of the report[6]. - The company faces risks related to industry regulation and national policy adjustments that could impact its operations[142]. - The company is exposed to intensified market competition, which may affect its market share and profitability if it fails to maintain its competitive edge[143]. - Fluctuations in raw material prices could adversely affect the company's operating performance, as raw materials constitute a significant portion of its costs[145]. Corporate Governance - The second board of directors consists of 7 members, including 3 independent directors, meeting the requirement of one-third independent representation[152]. - The second supervisory board is composed of 3 members, with 2 non-employee representatives elected by the shareholders' meeting and 1 employee representative elected by the employee representative assembly[153]. - Independent directors actively participated in board meetings and provided positive suggestions regarding the company's management and strategic direction[155]. - The company has established a dedicated information disclosure management system to ensure equal access to information for all shareholders[156]. - The company maintains independence in operations, finance, and decision-making, with no interference from the controlling shareholder[158]. Research and Development - The company has committed to continuous research and development investments, achieving significant innovative results during the reporting period[29]. - The company achieved significant R&D results in 2023, including the successful development of a third-generation synthetic catalyst with excellent selectivity and conversion rates, and breakthroughs in clean synthesis technologies for various aromatic monomers[31][32]. - The company has developed 73 patents, including 10 invention patents, showcasing its commitment to technological innovation[67]. - Research and development expenses increased by 30.48% to CNY 41,204,185.28, indicating a focus on innovation[73]. - The company is actively collaborating with universities and research institutions to address key challenges in the polymer materials sector[66]. Environmental Management - The company has invested 2.53 million RMB in environmental protection during the reporting period[192]. - The company has maintained compliance with environmental regulations, ensuring that all pollutants are discharged within the legal limits[193]. - The company has established a wastewater treatment plant and implemented a comprehensive treatment process for both domestic and production wastewater, ensuring good operational status[196]. - The air pollution control system utilizes low-nitrogen burners, with emissions of particulate matter, sulfur dioxide, and nitrogen oxides meeting relevant standards, also maintaining good operational status[196]. - Hazardous solid waste generated during production is classified and transferred to qualified disposal units, achieving zero solid waste discharge[196]. Market Position and Strategy - The company is committed to becoming a leader in its niche market, collaborating with universities and key polymer material laboratories to address critical issues in the domestic polymer materials sector[33]. - The company is positioned to benefit from the increasing demand for environmentally friendly materials, aligning with national goals for carbon neutrality[98]. - The company aims to enhance product differentiation and value through continuous upgrades in products, technologies, and processes, maintaining its industry leadership[133]. - The company plans to expand production capacity to meet growing market demand, as current capacity constraints limit its competitive advantage and market expansion[132]. - The company intends to gradually increase production scale to continuously improve market share[134]. Operational Efficiency - The company has invested in advanced business process management systems to strengthen the management and accounting of fundraising projects, improving operational efficiency and reducing internal control risks[34]. - The net cash flow from operating activities surged by 80.96% to CNY 205,598,020.53, reflecting improved operational efficiency[73]. - The company's total R&D expenditure for the period was ¥41,204,185.28, accounting for 4.04% of total revenue[86]. - The company's reliance on the top five suppliers was 44.01%, with total procurement from these suppliers amounting to ¥26,450.05 million[86]. - The company's operating costs are over 70% attributed to material costs, which are stable year-on-year[122].

江苏常青树新材料科技股份有限公司 审计报告 上会师报字(2024)第 2786 号 上会会计师事务所（特殊普通合伙） 中国 上海 - 我们认为,后附的财务报表在所有重大方面按照企业会计准则的规定编制,公 允反映了常青科技 2023 年 12 月 31 日的合并及公司财务状况以及 2023 年度的合并及 公司经营成果和现金流量。 二、形成审计意见的基础 我们按照中国注册会计师审计准则的规定执行了审计工作。审计报告的"注册 会计师对财务报表审计的责任"部分进一步阐述了我们在这些准则下的责任。按照 中国注册会计师职业道德守则,我们独立于常青科技,并履行了职业道德方面的其 他责任。我们相信,我们获取的审计证据是充分、适当的,为发表审计意见提供了 基础。 计师 李务所(特殊善通 rtilied Public Secountants (Special Genera 审计报告 上会师报字(2024)第 2786 号 江苏常青树新材料科技股份有限公司全体股东: 一、审计意见 我们审计了江苏常青树新材料科技股份有限公司（以下简称"常青科技"）财 务报表，包括 2023 年 12 月 31 日的合并及公司资产负债表，2023 年 ...

关于江苏常青树新材料科技股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审核报告 上会师报字(2024)第 2788 号 上会会计师事务所（特殊普通合伙） 中国 上海 计师 事务所(特殊善通合伙) Continted. Public Secountants (Special Goney 江苏常青树新材料科技股份有限公司 2023 年度非经营性资金占用及其他关联资金往来情况汇总表的 专项审核报告 上会师报字(2024)第 2788 号 江苏常青树新材料科技股份有限公司全体股东: 我们的责任是在执行审核工作的基础上对汇总表发表专项审核意见。 我们按照中国注册会计师审计准则的相关规定执行了审核工作。中国注册会计 师审计准则要求我们遵循中国注册会计师职业道德守则,计划和执行审核工作对汇 总表是否不存在重大错报获取合理保证。在审核的过程中,我们实施了包括检查会 计记录、重新计算相关项目金额等我们认为必要的程序。我们相信,我们的审核工 作为发表审核意见提供了合理的基础。 计师事务所(特殊普通、 rtified Public Secountants (Special Genera 我们认为,常青科技管理层 ...